Peroxynitrite activated near-infrared fluorescent probe for fluorescence and afterglow imaging of Alzheimer's disease brain
Source abstract
Abstract
Peroxynitrite anion (ONOO - ) is a crucial reactive species in pathological and physiological processes, and the elevated levels of ONOO - is concerned with various diseases mechanism. Researches demonstrated its significant contribution to the development of Alzheimer’s disease (AD). In order to elucidate the role of ONOO - in the evolution of AD, herein an activated fluorescent probe A-Hcy-Br was designed initiated the reaction with probe A-Hcy-Br using ONOO - . The probe has extraordinary specificity, sensitivity, and a rapid responsiveness for ONOO - . In addition, due to the excellent mitochondrial targeting ability of probe A-Hcy-Br, it enables effective monitor of brain cells during ONOO - oxidative stress in nerve cells. It is worth noting that A-Hcy-Br displayed well-behaved near-infrared emission and blood-brain barrier (BBB) permeability, encouraging ONOO - expression imaging in the brain. Moreover, the excellent afterglow imaging ability of A-Hcy-Br was successfully used for afterglow imaging in AD mice brain. A-Hcy-Br is further applicable for real-time fluorescence/afterglow monitoring of the therapeutic effect of the AD treatment drug donepezil hydrochloride, providing visual guidance for AD’s drug therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Molecular Sensors and Ion Detection · Sulfur Compounds in Biology · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice10.3390/antiox10030390 ↗
2. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics10.1038/nrd2222 ↗
3. Quasi-LD-targeted and ONOO- responsive fluorescent probe for investigating the interaction of nonalcoholic fatty liver with drug-induced liver injury10.1021/acs.analchem.2c05674 ↗
4. A highly sensitive and selective near-infrared fluorescent probe for imaging peroxynitrite in living cells and drug-induced liver injury mice10.1021/acs.analchem.3c00007 ↗
5. Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring10.1016/j.dyepig.2021.109466 ↗
6. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta10.1016/j.neuron.2013.04.014 ↗
7. High performance plasma amyloid-β biomarkers for Alzheimer's disease10.1038/nature25456 ↗
8. Selective visualization of the endogenous peroxynitrite in an inflamed mouse model by a mitochondria-targetable two-photon ratiometric fluorescent probe10.1021/jacs.6b10508 ↗
9. A rationally designed rhodamine-based fluorescent probe for molecular imaging of peroxynitrite in live cells and tissues10.1039/C6SC00012F ↗
10. Dual-channel fluorescent probe for the simultaneous monitoring of peroxynitrite and adenosine-5’-triphosphate in cellular applications10.1021/jacs.1c07954 ↗
11. Frontiers in probing Alzheimer's disease biomarkers with fluorescent small molecules10.1021/acscentsci.8b00951 ↗
12. Physicochemical-property guided design of a highly sensitive probe to image nitrosative stress in the pathology of stroke10.1039/C9SC03798E ↗
13. Screening anti-parkinson’s disease drugs in living mouse brains via a peroxynitrite-activated fluorescent probe10.1021/cbmi.4c00076 ↗
14. An activatable near-infrared afterglow theranostic prodrug with self-sustainable magnification effect of immunogenic cell death10.1002/anie.202209793 ↗
15. Achieving stimuli-responsive amorphous organic afterglow in single-component copolymer through self-doping10.1021/jacs.2c13632 ↗
16. Enhanced blue afterglow through molecular fusion for bio‐applications10.1002/anie.202201630 ↗
17. Nano-particles with ultrasound-induced afterglow luminescence for tumour-specific theranostics10.1038/s41551-022-00978-z ↗
18. H2S-activatable near-infrared afterglow luminescent probes for sensitive molecular imaging in vivo10.1038/s41467-020-14307-y ↗
19. An organic afterglow protheranostic nanoassembly
20. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
21. Peroxynitrite responsive second near-infrared cyanine dye J-Aggregate for drug-induced hepatotoxicity monitoring10.1021/cbmi.4c00111 ↗
22. An activity-based fluorescent probe for imaging fluctuations of peroxynitrite (ONOO-) in the Alzheimer's Disease brain
23. Lysosome-specific sensing and imaging of pH variations in vitro and in vivo utilizing a near-infrared boron complex10.1039/C8TB03353F ↗
24. Novel farvisible and near-infrared pH probes based on styrylcyanine for imaging intracellular pH in live cells10.1039/c2cc35363f ↗
25. Novel near infrared fluorescent pH sensors based on 1-aminoperylene bisimides covalently grafted onto poly(acryloylmorpholine)10.1039/c3cc39151e ↗
26. A unique approach to development of near-infrared fluorescent sensors for in vivo imaging10.1021/ja305802v ↗
27. A phosphinate-based near-infrared fluorescence probe for imaging the superoxide radical anion in in vitro and in vivo10.1039/C5CC09976E ↗
28. Mitochondria-targeted near-infrared fluorescent Off-On probe for selective detection of cysteine in living cells and in vivo10.1021/acsami.5b10607 ↗
29. Ratiometric near-infrared fluorescent probes based on through-bond energy transfer and π-conjugation modulation between tetraphenylethene and hemicyanine moieties for sensitive detection of pH changes in live cells10.1021/acs.bioconjchem.8b00111 ↗
30. A unique class of near-infrared functional fluorescent dyes with carboxylic-acid-modulated fluorescence ON/OFF switching: rational design, synthesis, optical properties, theoretical calculations, and applications for fluorescence imaging in living animals10.1021/ja209292b ↗
31. Hemicyanine-based high resolution ratiometric near-Infrared fluorescent probe for monitoring pH changes in vivo10.1021/ac5045498 ↗
32. New near-infrared fluorescence imaging platform with large stokes shift for carboxylesterase 2 detection in thyroid cancer and inflammatory diseases diagnosis10.1021/acs.analchem.3c04399 ↗
33. Increased Iron and free radical generation in preclinical alzheimer disease and mild cognitive impairment10.3233/JAD-2010-1239 ↗
34. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease
35. A near-IR ratiometric fluorescent probe for the precise tracking of senescence: a multidimensional sensing assay of biomarkers in cell senescence pathways10.1039/D4SC00595C ↗
36. Near-infrared mito-specific fluorescent probe for ratiometric detection and imaging of alkaline phosphatase activity with high sensitivity10.1039/C8TB02799D ↗
37. “Four-In-One” design of a hemicyanine-based modular scaffold for high-contrast activatable molecular afterglow imaging10.1021/jacs.2c11466 ↗
38. The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease10.1016/j.biopha.2023.114223 ↗
39. Alzheimer's disease: donepezil effects on cholesterol and oxysterol plasma levels10.1002/alz.044144 ↗
40. Subcutaneous implantable microneedle System for the treatment of alzheimer's disease by delivering donepezil10.1021/acs.biomac.2c01155 ↗
41. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
42. The efficacy of donepezil administration on acetylcholin-esterase activity and altered redox homeostasis in Alzheimer's disease10.1016/j.biopha.2017.03.101 ↗
43. A drug for Alzheimer's disease, promotes oligodendrocyte genera-tion and remyelination10.1038/s41401-018-0206-4 ↗
44. A novel targeted and high-efficiency nanosystem for combinational therapy for Alzheimer's Disease10.1002/advs.201902906 ↗
45. Alzheimer's disease: experimental models and reality10.1007/s00401-016-1662-x ↗
46. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease10.1038/s41467-020-18525-2 ↗
47. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy10.1126/sciadv.abc7031 ↗